Cytokinetics Ownership 2024 | Who Owns Cytokinetics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

35.74%

Insider Ownership

0.50%

Retail Ownership

63.76%

Institutional Holders

161.00

Cytokinetics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.12.53%0.02%12,414,773-3,687,297-22.90%870,399,734Mar 31, 2024
FMR LLC11.00%0.05%10,901,143-2,106,640-16.20%764,279,169Mar 31, 2024
VANGUARD GROUP INC10.09%0.01%9,997,076-1,019,813-9.26%700,894,999Mar 31, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.5.17%0.22%5,121,5892,892,104129.72%359,075,000Mar 31, 2024
BANK OF AMERICA CORP /DE/4.82%0.03%4,777,6284,510,8571690.91%334,959,499,000Mar 31, 2024
STATE STREET CORP4.56%0.01%4,520,358-1,373,000-23.30%316,922,299Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP4.02%0.05%3,981,460-2,507,040-38.64%279,140,161Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/2.96%0.03%2,930,948-313,302-9.66%205,489,000Mar 31, 2024
MARSHALL WACE, LLP2.58%0.27%2,556,8031,930,716308.38%179,257,459Mar 31, 2024
RTW INVESTMENTS, LP2.55%2.61%2,525,080--177,033,359Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC2.27%0.01%2,247,165157,0407.51%157,571,283Mar 31, 2024
VESTAL POINT CAPITAL, LP2.17%12.47%2,150,0002,100,0004200.00%150,736,500Mar 31, 2024
BOXER CAPITAL, LLC2.12%7.27%2,100,000--147,231,000Mar 31, 2024
ALLIANCEBERNSTEIN L.P.1.79%0.04%1,770,0651,647,8181347.94%124,099,257Mar 31, 2024
PFM HEALTH SCIENCES, LP1.77%5.79%1,757,192--123,196,731Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA1.77%0.13%1,753,646381,40227.79%123,114,091Mar 31, 2024
POLAR CAPITAL HOLDINGS PLC1.62%0.59%1,605,576188,52213.30%112,566,933Mar 31, 2024
ARMISTICE CAPITAL, LLC1.54%1.42%1,525,6881,525,688100.00%106,965,986Mar 31, 2024
INVESCO LTD.1.33%0.02%1,317,53874,5586.00%92,372,590Mar 31, 2024
NORTHERN TRUST CORP1.12%0.01%1,111,44055,4635.25%77,923,060Mar 31, 2024

Cytokinetics's largest institutional shareholder is BLACKROCK INC., holding 12.53% of the company's total share outstanding, currently valued at $870.40M. The top 10 institutional shareholders own together 60.29% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUPERSTRING CAPITAL MANAGEMENT LP0.28%12.93%278,915101,31257.04%19,554,730Mar 31, 2024
VESTAL POINT CAPITAL, LP2.17%12.47%2,150,0002,100,0004200.00%150,736,500Mar 31, 2024
CHECKPOINT CAPITAL L.P.0.19%8.90%190,000-40,000-17.39%13,320,900Mar 31, 2024
SATURN V CAPITAL MANAGEMENT LLC0.27%7.41%263,701-184,443-41.16%18,488,077Mar 31, 2024
BOXER CAPITAL, LLC2.12%7.27%2,100,000--147,231,000Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC0.40%6.35%398,100-1,900-0.47%27,910,791Mar 31, 2024
PFM HEALTH SCIENCES, LP1.77%5.79%1,757,192--123,196,731Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.32%5.08%319,510227,428246.98%22,400,846Mar 31, 2024
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A.0.47%4.98%461,018116,53433.83%32,321,972Mar 31, 2024
PROSIGHT MANAGEMENT, LP0.25%4.78%245,000245,000100.00%17,176,950Mar 31, 2024
FIRST TURN MANAGEMENT, LLC0.43%4.51%430,349-377,095-46.70%30,171,768Mar 31, 2024
FOURWORLD CAPITAL MANAGEMENT LLC0.10%4.41%100,000-70,000-41.18%7,011,000Mar 31, 2024
MELQART ASSET MANAGEMENT (UK) LTD0.99%4.30%983,395983,395100.00%68,945,823Mar 31, 2024
FINEPOINT CAPITAL LP0.24%4.28%238,046-193,647-44.86%16,689,405Mar 31, 2024
SARISSA CAPITAL MANAGEMENT LP0.30%3.68%300,000300,000100.00%21,033,000Mar 31, 2024
MELQART ASSET MANAGEMENT (UK) LTD0.81%3.50%800,100800,100100.00%56,095,011Mar 31, 2024
HAP TRADING, LLC0.40%3.18%395,529395,529100.00%27,730,538Mar 31, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC0.45%2.93%450,000250,000125.00%31,549,500Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.0.28%2.77%281,67157,85125.85%19,747,954Mar 31, 2024
RTW INVESTMENTS, LP2.55%2.61%2,525,080--177,033,359Mar 31, 2024

The largest Cytokinetics shareholder by % of total assets is SUPERSTRING CAPITAL MANAGEMENT LP. The company owns 278.92K shares of Cytokinetics (CYTK), representing 12.93% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BANK OF AMERICA CORP /DE/4.82%0.03%4,777,6284,510,8571690.91%334,959,499,000Mar 31, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.5.17%0.22%5,121,5892,892,104129.72%359,075,000Mar 31, 2024
VESTAL POINT CAPITAL, LP2.17%12.47%2,150,0002,100,0004200.00%150,736,500Mar 31, 2024
MARSHALL WACE, LLP2.58%0.27%2,556,8031,930,716308.38%179,257,459Mar 31, 2024
ALLIANCEBERNSTEIN L.P.1.79%0.04%1,770,0651,647,8181347.94%124,099,257Mar 31, 2024
ARMISTICE CAPITAL, LLC1.54%1.42%1,525,6881,525,688100.00%106,965,986Mar 31, 2024
PENTWATER CAPITAL MANAGEMENT LP1.09%0.78%1,080,0001,080,000100.00%75,718,800Mar 31, 2024
MELQART ASSET MANAGEMENT (UK) LTD0.99%4.30%983,395983,395100.00%68,945,823Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.95%0.01%945,700945,700100.00%66,303,027Mar 31, 2024
PENTWATER CAPITAL MANAGEMENT LP0.93%0.66%920,900920,900100.00%64,564,299Mar 31, 2024
MELQART ASSET MANAGEMENT (UK) LTD0.81%3.50%800,100800,100100.00%56,095,011Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.77%0.19%760,319760,319100.00%53,305,965Mar 31, 2024
BROWN ADVISORY INC0.77%0.07%759,534759,534100.00%53,250,930Mar 31, 2024
WESTFIELD CAPITAL MANAGEMENT CO LP0.74%0.27%731,386731,386100.00%51,277,472Mar 31, 2024
HAP TRADING, LLC0.87%0.90%862,300712,300474.87%7,826,315Mar 31, 2024
ARMISTICE CAPITAL, LLC0.71%0.65%700,000700,000100.00%49,077,000Mar 31, 2024
ORBIMED ADVISORS LLC0.69%0.88%682,700682,700100.00%47,864,097Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.62%0.01%616,900616,900100.00%43,250,859Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP0.61%1.36%600,000600,000100.00%42,066,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.58%0.01%576,477576,477100.00%40,416,802Mar 31, 2024

As of Mar 31 2024, Cytokinetics's largest institutional buyer is BANK OF AMERICA CORP /DE/. The company purchased 4.51M stocks of CYTK, valued at $334.96B.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.12.53%0.02%12,414,773-3,687,297-22.90%870,399,734Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP4.02%0.05%3,981,460-2,507,040-38.64%279,140,161Mar 31, 2024
FMR LLC11.00%0.05%10,901,143-2,106,640-16.20%764,279,169Mar 31, 2024
JANUS HENDERSON GROUP PLC0.80%0.03%797,372-1,771,033-68.95%55,900,952Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP0.10%0.57%100,000-1,525,000-93.85%7,011,000Mar 31, 2024
MORGAN STANLEY0.96%0.01%954,858-1,446,724-60.24%66,945,124Mar 31, 2024
LORD, ABBETT & CO. LLC0.20%0.05%198,158-1,409,654-87.68%13,892,000Mar 31, 2024
STATE STREET CORP4.56%0.01%4,520,358-1,373,000-23.30%316,922,299Mar 31, 2024
DEEP TRACK CAPITAL, LP----1,347,300-100.00%-Mar 31, 2024
VANGUARD GROUP INC10.09%0.01%9,997,076-1,019,813-9.26%700,894,999Mar 31, 2024
TOMS CAPITAL INVESTMENT MANAGEMENT LP----1,000,000-100.00%-Mar 31, 2024
FARALLON CAPITAL MANAGEMENT LLC0.10%0.03%102,400-985,372-90.59%7,179,264Mar 31, 2024
CAPTION MANAGEMENT, LLC0.81%0.86%803,500-885,100-52.42%56,333,385Mar 31, 2024
CAPTION MANAGEMENT, LLC0.48%0.51%475,900-876,000-64.80%33,365,349Mar 31, 2024
ARTAL GROUP S.A.0.51%0.90%506,584-707,700-58.28%35,516,604Mar 31, 2024
ANTARA CAPITAL LP----700,000-100.00%-Mar 31, 2024
BARCLAYS PLC0.03%0.00%28,000-677,800-96.03%1,963,000Mar 31, 2024
IKARIAN CAPITAL, LLC----603,500-100.00%-Mar 31, 2024
DARWIN GLOBAL MANAGEMENT, LTD.----600,000-100.00%-Mar 31, 2024
ASSENAGON ASSET MANAGEMENT S.A.----554,658-100.00%-Mar 31, 2024

As of Mar 31 2024, Cytokinetics's biggest institutional seller is BLACKROCK INC.. The company sold -3.69M shares of CYTK, valued at $870.40M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC1.54%1.42%1,525,6881,525,688100.00%106,965,986Mar 31, 2024
PENTWATER CAPITAL MANAGEMENT LP1.09%0.78%1,080,0001,080,000100.00%75,718,800Mar 31, 2024
MELQART ASSET MANAGEMENT (UK) LTD0.99%4.30%983,395983,395100.00%68,945,823Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.95%0.01%945,700945,700100.00%66,303,027Mar 31, 2024
PENTWATER CAPITAL MANAGEMENT LP0.93%0.66%920,900920,900100.00%64,564,299Mar 31, 2024
MELQART ASSET MANAGEMENT (UK) LTD0.81%3.50%800,100800,100100.00%56,095,011Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.77%0.19%760,319760,319100.00%53,305,965Mar 31, 2024
BROWN ADVISORY INC0.77%0.07%759,534759,534100.00%53,250,930Mar 31, 2024
WESTFIELD CAPITAL MANAGEMENT CO LP0.74%0.27%731,386731,386100.00%51,277,472Mar 31, 2024
ARMISTICE CAPITAL, LLC0.71%0.65%700,000700,000100.00%49,077,000Mar 31, 2024
ORBIMED ADVISORS LLC0.69%0.88%682,700682,700100.00%47,864,097Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.62%0.01%616,900616,900100.00%43,250,859Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP0.61%1.36%600,000600,000100.00%42,066,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.58%0.01%576,477576,477100.00%40,416,802Mar 31, 2024
LAURION CAPITAL MANAGEMENT LP0.52%0.31%519,918519,918100.00%36,451,451Mar 31, 2024
COWEN AND COMPANY, LLC0.51%0.51%510,000510,000100.00%13,068,749Mar 31, 2024
IRON TRIANGLE PARTNERS LP0.30%2.15%300,000300,000100.00%21,033,000Mar 31, 2024
SARISSA CAPITAL MANAGEMENT LP0.30%3.68%300,000300,000100.00%21,033,000Mar 31, 2024
PENTWATER CAPITAL MANAGEMENT LP0.29%0.21%290,000290,000100.00%20,331,900Mar 31, 2024
PROSIGHT MANAGEMENT, LP0.25%4.78%245,000245,000100.00%17,176,950Mar 31, 2024
SEGANTII CAPITAL MANAGEMENT LTD0.21%0.96%210,000210,000100.00%14,723,100Mar 31, 2024
BARCLAYS PLC0.19%0.00%188,200188,200100.00%13,195,000Mar 31, 2024
SIMPLEX TRADING, LLC0.18%0.01%178,309178,309100.00%12,501,000Mar 31, 2024
TROLUCE CAPITAL ADVISORS LLC0.18%1.48%175,000175,000100.00%12,269,250Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP0.17%0.38%166,000166,000100.00%11,638,260Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.16%0.08%162,319162,319100.00%11,380,185Mar 31, 2024
REDMILE GROUP, LLC0.16%0.42%161,600161,600100.00%11,329,776Mar 31, 2024
KRYGER CAPITAL LTD0.15%1.92%146,838146,838100.00%10,294,812Mar 31, 2024
RETIREMENT SYSTEMS OF ALABAMA0.12%0.03%123,132123,132100.00%8,632,785Mar 31, 2024
KINGDON CAPITAL MANAGEMENT, L.L.C.0.12%0.89%116,000116,000100.00%8,132,760Mar 31, 2024
NOMURA HOLDINGS INC0.10%0.02%101,609101,609100.00%7,123,807Mar 31, 2024
HBK INVESTMENTS L P0.10%0.03%100,000100,000100.00%7,011,000Mar 31, 2024
DECHENG CAPITAL LLC0.09%0.88%94,04394,043100.00%6,593,355Mar 31, 2024
POLAR ASSET MANAGEMENT PARTNERS INC.0.09%0.11%92,30092,300100.00%6,471,153Mar 31, 2024
EMERALD ADVISERS, LLC0.09%0.26%91,56191,561100.00%6,419,342Mar 31, 2024
EMERALD MUTUAL FUND ADVISERS TRUST0.07%0.26%72,08072,080100.00%5,053,529Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.07%0.22%67,07667,076100.00%4,702,698Mar 31, 2024
D. E. SHAW & CO., INC.0.06%0.00%64,30064,300100.00%4,508,073Mar 31, 2024
EISLER CAPITAL (US) LLC0.06%0.10%60,00060,000100.00%4,206,600Mar 31, 2024
VAN ECK ASSOCIATES CORP0.06%0.01%57,89357,893100.00%4,059,000Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC0.05%0.97%50,00050,000100.00%3,505,500Mar 31, 2024
CLEARLINE CAPITAL LP0.05%0.16%48,03548,035100.00%3,367,734Mar 31, 2024
SANDLER CAPITAL MANAGEMENT0.05%0.24%46,00046,000100.00%3,225,060Mar 31, 2024
EISLER CAPITAL (US) LLC0.05%0.08%45,00045,000100.00%3,154,950Mar 31, 2024
WCM INVESTMENT MANAGEMENT, LLC0.04%0.01%43,86643,866100.00%3,075,445Mar 31, 2024
CONCENTRIC CAPITAL STRATEGIES, LP0.04%0.16%40,20740,207100.00%2,818,913Mar 31, 2024
ZIMMER PARTNERS, LP0.04%0.06%38,60038,600100.00%2,706,246Mar 31, 2024
FIRST TRUST ADVISORS LP0.04%0.00%37,94937,949100.00%2,660,604Mar 31, 2024
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP0.04%0.04%36,87536,875100.00%2,583,462Mar 31, 2024
D. E. SHAW & CO., INC.0.04%0.00%36,55436,554100.00%2,562,801Mar 31, 2024
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC0.03%0.05%33,07133,071100.00%2,318,608Mar 31, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND0.03%0.01%30,00030,000100.00%2,103,300Mar 31, 2024
EISLER CAPITAL (US) LLC0.03%0.05%30,00030,000100.00%2,103,300Mar 31, 2024
DRW SECURITIES, LLC0.03%0.05%26,90026,900100.00%1,885,959Mar 31, 2024
CLEAR STREET MARKETS LLC0.03%0.30%26,30026,300100.00%1,844,000Mar 31, 2024
SQUAREPOINT OPS LLC0.03%0.00%25,70025,700100.00%1,801,827Mar 31, 2024
CARLSON CAPITAL L P0.03%0.14%25,00025,000100.00%1,752,750Mar 31, 2024
STATE OF MICHIGAN RETIREMENT SYSTEM0.02%0.01%24,10024,100100.00%1,689,651Mar 31, 2024
PALOMA PARTNERS MANAGEMENT CO0.02%0.09%23,39423,394100.00%1,640,153Mar 31, 2024
NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC0.02%0.04%21,87021,870100.00%1,533,306Mar 31, 2024
CASTLEARK MANAGEMENT LLC0.02%0.06%20,98020,980100.00%1,470,908Mar 31, 2024
NEW MEXICO EDUCATIONAL RETIREMENT BOARD0.02%0.05%20,50020,500100.00%1,437,000Mar 31, 2024
NOMURA ASSET MANAGEMENT CO LTD0.02%0.01%20,20820,208100.00%1,416,783Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.02%0.17%20,16020,160100.00%1,413,418Mar 31, 2024
XR SECURITIES LLC0.02%0.04%18,37318,373100.00%1,288,131Mar 31, 2024
XR SECURITIES LLC0.02%0.04%18,20018,200100.00%1,276,002Mar 31, 2024
LOS ANGELES CAPITAL MANAGEMENT LLC0.02%0.00%17,81717,817100.00%1,249,150Mar 31, 2024
SQUAREPOINT OPS LLC0.02%0.00%17,50017,500100.00%1,226,925Mar 31, 2024
CAPITAL FUND MANAGEMENT S.A.0.02%0.00%15,60315,603100.00%1,093,926Mar 31, 2024
PACER ADVISORS, INC.0.02%0.00%15,44915,449100.00%1,083,129Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.01%0.01%14,60014,600100.00%1,023,606Mar 31, 2024
DARK FOREST CAPITAL MANAGEMENT LP0.01%0.17%14,43714,437100.00%1,012,178Mar 31, 2024
ROYCE & ASSOCIATES LP0.01%0.01%14,25014,250100.00%999,068Mar 31, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.01%0.25%13,96513,965100.00%979,061Mar 31, 2024
PHOENIX HOLDINGS LTD.0.01%0.01%12,62312,623100.00%882,449Mar 31, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC0.01%0.00%11,59311,593100.00%812,785Mar 31, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC0.01%0.01%11,39011,390100.00%798,553Mar 31, 2024
AIGEN INVESTMENT MANAGEMENT, LP0.01%0.16%10,65310,653100.00%746,882Mar 31, 2024
FNY INVESTMENT ADVISERS, LLC0.01%0.42%10,05510,055100.00%704,000Mar 31, 2024
TUDOR INVESTMENT CORP ET AL0.01%0.00%9,7009,700100.00%680,067Mar 31, 2024
CANNON GLOBAL INVESTMENT MANAGEMENT, LLC0.01%1.83%9,7009,700100.00%680,067Mar 31, 2024
FEDERATED HERMES, INC.0.01%0.00%8,5688,568100.00%600,702Mar 31, 2024
SECURIAN ASSET MANAGEMENT, INC0.01%0.02%8,0638,063100.00%565,297Mar 31, 2024
CETERA ADVISORS LLC0.01%0.00%7,5797,579100.00%531,364Mar 31, 2024
CERITY PARTNERS LLC0.01%0.00%7,4657,465100.00%523,370Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.01%0.00%7,4007,400100.00%520,000Mar 31, 2024
DNB ASSET MANAGEMENT AS0.01%0.00%6,5866,586100.00%461,547Mar 31, 2024
FIRST BANK & TRUST0.01%0.09%6,4546,454100.00%452,490Mar 31, 2024
CI INVESTMENTS INC.0.01%0.00%5,9395,939100.00%416,000Mar 31, 2024
BRIDGEFRONT CAPITAL, LLC0.01%0.30%5,6915,691100.00%398,996Mar 31, 2024
POINT72 HONG KONG LTD0.01%0.02%5,3455,345100.00%374,741Mar 31, 2024
CHEMISTRY WEALTH MANAGEMENT LLC0.01%0.10%5,2145,214100.00%365,554Mar 31, 2024
CLARIVEST ASSET MANAGEMENT LLC0.01%0.04%5,0865,086100.00%356,580Mar 31, 2024
GABELLI FUNDS LLC0.01%0.00%5,0005,000100.00%350,550Mar 31, 2024
CERTUITY, LLC0.01%0.03%5,0005,000100.00%350,550Mar 31, 2024
KNOTT DAVID M JR0.01%0.12%5,0005,000100.00%351,000Mar 31, 2024
B. METZLER SEEL. SOHN & CO. AG0.00%0.00%4,6984,698100.00%329,377Mar 31, 2024
PRELUDE CAPITAL MANAGEMENT, LLC0.00%0.01%4,0004,000100.00%280,440Mar 31, 2024
HARBOR CAPITAL ADVISORS, INC.0.00%0.03%3,5443,544100.00%248,000Mar 31, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.0.00%0.00%3,3133,313100.00%232,274Mar 31, 2024

Cytokinetics's largest new institutional shareholder by number of shares is ARMISTICE CAPITAL, LLC, purchased 1.53M shares, valued at $106.97M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DEEP TRACK CAPITAL, LP----1,347,300-100.00%-Mar 31, 2024
TOMS CAPITAL INVESTMENT MANAGEMENT LP----1,000,000-100.00%-Mar 31, 2024
ANTARA CAPITAL LP----700,000-100.00%-Mar 31, 2024
IKARIAN CAPITAL, LLC----603,500-100.00%-Mar 31, 2024
DARWIN GLOBAL MANAGEMENT, LTD.----600,000-100.00%-Mar 31, 2024
ASSENAGON ASSET MANAGEMENT S.A.----554,658-100.00%-Mar 31, 2024
SOFINNOVA INVESTMENTS, INC.----414,207-100.00%-Mar 31, 2024
BANK OF AMERICA CORP /DE/----411,600-100.00%-Mar 31, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC----400,000-100.00%-Mar 31, 2024
NATIXIS----315,831-100.00%-Mar 31, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC----220,384-100.00%-Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.----220,000-100.00%-Mar 31, 2024
LMR PARTNERS LLP----212,700-100.00%-Mar 31, 2024
PUBLIC SECTOR PENSION INVESTMENT BOARD----203,472-100.00%-Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC----192,000-100.00%-Mar 31, 2024
CITIGROUP INC----180,900-100.00%-Mar 31, 2024
CAPSTONE INVESTMENT ADVISORS, LLC----153,900-100.00%-Mar 31, 2024
TIG ADVISORS, LLC----122,500-100.00%-Mar 31, 2024
GTS SECURITIES LLC----116,901-100.00%-Mar 31, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC----110,017-100.00%-Mar 31, 2024
NICHOLAS INVESTMENT PARTNERS, LP----102,572-100.00%-Mar 31, 2024
POLAR ASSET MANAGEMENT PARTNERS INC.----100,000-100.00%-Mar 31, 2024
SHAOLIN CAPITAL MANAGEMENT LLC----100,000-100.00%-Mar 31, 2024
TACONIC CAPITAL ADVISORS LP----60,000-100.00%-Mar 31, 2024
COWEN AND COMPANY, LLC----56,828-100.00%-Mar 31, 2024
WOODLINE PARTNERS LP----42,652-100.00%-Mar 31, 2024
WALLEYE TRADING LLC----41,269-100.00%-Mar 31, 2024
CORBIN CAPITAL PARTNERS, L.P.----40,000-100.00%-Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.----35,800-100.00%-Mar 31, 2024
MARYLAND STATE RETIREMENT & PENSION SYSTEM----35,637-100.00%-Mar 31, 2024
CRESTLINE MANAGEMENT, LP----34,887-100.00%-Mar 31, 2024
Y-INTERCEPT (HONG KONG) LTD----33,215-100.00%-Mar 31, 2024
PERCEPTIVE ADVISORS LLC----30,317-100.00%-Mar 31, 2024
STEMPOINT CAPITAL LP----24,111-100.00%-Mar 31, 2024
BARDIN HILL MANAGEMENT PARTNERS LP----24,096-100.00%-Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----23,300-100.00%-Mar 31, 2024
SIMPLIFY ASSET MANAGEMENT INC.----21,797-100.00%-Mar 31, 2024
FRED ALGER MANAGEMENT, LLC----20,921-100.00%-Mar 31, 2024
ATHOS CAPITAL LTD----20,000-100.00%-Mar 31, 2024
ALTIUM CAPITAL MANAGEMENT LP----20,000-100.00%-Mar 31, 2024
WINTON GROUP LTD----17,596-100.00%-Mar 31, 2024
SHAY CAPITAL LLC----17,500-100.00%-Mar 31, 2024
OSTERWEIS CAPITAL MANAGEMENT INC----17,340-100.00%-Mar 31, 2024
XR SECURITIES LLC----16,900-100.00%-Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP----15,764-100.00%-Mar 31, 2024
LEGATO CAPITAL MANAGEMENT LLC----15,636-100.00%-Mar 31, 2024
TWO SIGMA INVESTMENTS, LP----15,000-100.00%-Mar 31, 2024
CINCTIVE CAPITAL MANAGEMENT LP----15,000-100.00%-Mar 31, 2024
EVERENCE CAPITAL MANAGEMENT INC----13,510-100.00%-Mar 31, 2024
AMUNDI----13,168-100.00%-Mar 31, 2024
UBS GROUP AG----12,800-100.00%-Mar 31, 2024
CAPTRUST FINANCIAL ADVISORS----12,258-100.00%-Mar 31, 2024
HEADLANDS TECHNOLOGIES LLC----10,508-100.00%-Mar 31, 2024
UBS OCONNOR LLC----10,000-100.00%-Mar 31, 2024
J. GOLDMAN & CO LP----8,095-100.00%-Mar 31, 2024
SOUTH DAKOTA INVESTMENT COUNCIL----8,021-100.00%-Mar 31, 2024
CIBC ASSET MANAGEMENT INC----6,643-100.00%-Mar 31, 2024
ORACLE ALPHA INC.----6,206-100.00%-Mar 31, 2024
VIRTUS INVESTMENT ADVISERS, INC.----4,718-100.00%-Mar 31, 2024
XTX TOPCO LTD----4,178-100.00%-Mar 31, 2024
GSA CAPITAL PARTNERS LLP----4,165-100.00%-Mar 31, 2024
FIRST TRUST DIRECT INDEXING L.P.----3,989-100.00%-Mar 31, 2024
TWO SIGMA SECURITIES, LLC----3,822-100.00%-Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC----3,500-100.00%-Mar 31, 2024
SEQUOIA FINANCIAL ADVISORS, LLC----3,147-100.00%-Mar 31, 2024
JOURNEY STRATEGIC WEALTH LLC----2,914-100.00%-Mar 31, 2024
CAPROCK GROUP, LLC----2,582-100.00%-Mar 31, 2024
SAGE RHINO CAPITAL LLC----2,439-100.00%-Mar 31, 2024
SKAANA MANAGEMENT L.P.----1,800-100.00%-Mar 31, 2024
TORNO CAPITAL, LLC----1,000-100.00%-Mar 31, 2024
BANQUE CANTONALE VAUDOISE----968-100.00%-Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC----950-100.00%-Mar 31, 2024
VIRTUS FUND ADVISERS, LLC----789-100.00%-Mar 31, 2024
ATIKA CAPITAL MANAGEMENT LLC----497-100.00%-Mar 31, 2024
LEVEL FINANCIAL ADVISORS, INC.----264-100.00%-Mar 31, 2024
NATIONAL BANK OF CANADA /FI/----150-100.00%-Mar 31, 2024
DAGCO, INC.----68-100.00%-Mar 31, 2024
FNY INVESTMENT ADVISERS, LLC----30-100.00%-Mar 31, 2024
PARKSIDE FINANCIAL BANK & TRUST----22-100.00%-Mar 31, 2024
GPS WEALTH STRATEGIES GROUP, LLC----16-100.00%-Mar 31, 2024
ASSETMARK, INC----4-100.00%-Mar 31, 2024
ADVISORNET FINANCIAL, INC----3-100.00%-Mar 31, 2024

Cytokinetics's largest sold out institutional shareholder by shares sold is DEEP TRACK CAPITAL, LP, sold -1.35M shares, valued at -, as of undefined.

Cytokinetics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Manager Directed Portfolios1.74%285,394--Jan 31, 2024
TRI-CONTINENTAL CORP0.73%4,000,000--Dec 31, 2023
Virtus Equity & Convertible Income Fund0.71%1,405,000--Jan 31, 2024
Virtus Dividend, Interest & Premium Strategy Fund0.67%1,580,000--Jan 31, 2024
Virtus Diversified Income & Convertible Fund0.56%1,130,000--Jan 31, 2024
BANCROFT FUND LTD0.54%750,000750,000-Dec 29, 2023
ELLSWORTH GROWTH & INCOME FUND LTD0.53%750,000750,000-Dec 29, 2023
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC0.50%400,000400,000-Dec 29, 2023
TRI-CONTINENTAL CORP0.46%2,500,000-2,000,000-44.44%Dec 31, 2023
Virtus Convertible & Income Fund II0.45%1,680,000--Jan 31, 2024
Virtus Convertible & Income Fund0.44%2,190,000--Jan 31, 2024
Tema ETF Trust0.41%18,40812,909234.75%Feb 29, 2024
HARTFORD HLS SERIES FUND II INC0.38%92,882-7,669-7.63%Dec 31, 2023
Virtus Equity & Convertible Income Fund0.27%540,000540,000-Jan 31, 2024
Virtus Dividend, Interest & Premium Strategy Fund0.27%635,000635,000-Jan 31, 2024
Virtus Diversified Income & Convertible Fund0.23%460,000460,000-Jan 31, 2024
FIDELITY ADVISOR SERIES VII0.21%1,805,171-115,400-6.01%Jan 31, 2024
Virtus Strategy Trust0.20%4,325,0004,325,000-Dec 29, 2023
T. Rowe Price Small-Cap Stock Fund, Inc.0.19%714,800155,40027.78%Dec 31, 2023
PRUDENTIAL SECTOR FUNDS, INC.0.19%395,827--Feb 29, 2024
Virtus Strategy Trust0.17%3,700,000--Dec 29, 2023
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.17%154,520-397,470-72.01%Jan 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.16%810,675470,066138.01%Dec 31, 2023
TETON WESTWOOD FUNDS0.15%100,000100,000-Dec 29, 2023
Virtus Convertible & Income Fund II0.15%575,000575,000-Jan 31, 2024
AB DISCOVERY GROWTH FUND, INC.0.15%223,117223,117-Jan 31, 2024
Virtus Convertible & Income Fund0.15%725,000725,000-Jan 31, 2024
VANGUARD ADMIRAL FUNDS0.14%594,11891,61118.23%Feb 29, 2024
VANGUARD VALLEY FORGE FUNDS0.13%64,453--Dec 31, 2023
T. Rowe Price Quantitative Management Funds, Inc.0.13%475,10085,40021.91%Dec 31, 2023
BlackRock Health Sciences Trust II0.10%276,900--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND IV0.10%265,00047,00021.56%Dec 31, 2023
BNY MELLON INDEX FUNDS, INC.0.09%99,461-11,564-10.42%Jan 31, 2024
BNY MELLON INVESTMENT PORTFOLIOS0.08%48,922--Mar 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.08%1,158,2151,158,215-Dec 31, 2023
TEKLA LIFE SCIENCES INVESTORS0.08%44,412-42,532-48.92%Dec 31, 2023
TEKLA HEALTHCARE INVESTORS0.08%85,848-46,233-35.00%Dec 31, 2023
LORD ABBETT RESEARCH FUND INC0.06%58,586--Feb 29, 2024
Voya VARIABLE PRODUCTS TRUST0.05%13,861-253-1.79%Dec 31, 2023
FIDELITY CAPITAL TRUST0.05%483,355-46,000-8.69%Jan 31, 2024
VANGUARD EXPLORER FUND0.05%560,128-560,058-50.00%Jan 31, 2024
T. Rowe Price Small-Cap Value Fund, Inc.0.04%328,400-1,300-0.39%Dec 31, 2023
Nuveen NASDAQ 100 Dynamic Overwrite Fund0.04%5,067--Dec 31, 2023
BlackRock Health Sciences Trust0.04%16,280--Dec 31, 2023
Voya EQUITY TRUST0.04%54,2263,4266.74%Feb 29, 2024
FIDELITY SELECT PORTFOLIOS0.04%2,341,721-359,250-13.30%Feb 29, 2024
AMERICAN CENTURY MUTUAL FUNDS, INC.0.03%346,402-2,377,927-87.28%Jan 31, 2024
Humankind Benefit Corp0.03%74720.27%Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.03%14,2893042.17%Dec 31, 2023
DRIEHAUS MUTUAL FUNDS0.03%229,000--Dec 29, 2023
WASATCH FUNDS TRUST0.03%252,009--Mar 31, 2024
VANGUARD SPECIALIZED FUNDS0.03%1,469,555-1,864,975-55.93%Jan 31, 2024
Fidelity Central Investment Portfolios LLC0.03%500,000--Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC0.03%169,59011,6537.38%Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND III0.02%210,10043,00025.73%Dec 31, 2023
SYNTAX ETF TRUST0.02%77117028.29%Dec 31, 2023
T. Rowe Price Equity Series, Inc.0.02%39,17322,831139.71%Dec 31, 2023
VANGUARD INDEX FUNDS0.02%9,985,0191,655,17619.87%Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND0.02%375,83173,80024.43%Dec 31, 2023
FIDELITY SECURITIES FUND0.02%1,896,313-76,747-3.89%Jan 31, 2024
AMERICAN CENTURY VARIABLE PORTFOLIOS INC0.02%48,209-80,772-62.62%Dec 31, 2023
AMG FUNDS III0.02%3,142--Feb 29, 2024
T. Rowe Price Equity Funds, Inc.0.02%314,05267,60027.43%Dec 31, 2023
ALGER FUNDS0.02%16,97016,970-Jan 31, 2024
VICTORY VARIABLE INSURANCE FUNDS0.01%6,850-9,120-57.11%Dec 31, 2023
FORUM FUNDS II0.01%10,800--Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.01%32,7585271.64%Feb 29, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.01%37,661-20,936-35.73%Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,182--Dec 31, 2023
ALLSPRING VARIABLE TRUST0.01%4,491--Dec 31, 2023
Vericimetry Funds0.01%820--Dec 31, 2023
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.01%18,000--Dec 31, 2023
FIDELITY ADVISOR SERIES I0.01%1,325,083-341,019-20.47%Feb 29, 2024
RYDEX SERIES FUNDS0.01%29,771-3,526-10.59%Dec 31, 2023
JNL VARIABLE FUND LLC0.01%36,879--Mar 31, 2020
ADVENT CONVERTIBLE & INCOME FUND0.01%20,00020,000-Jan 31, 2024
ALPS ETF Trust0.01%63,110--Feb 29, 2024
AIM GROWTH SERIES (INVESCO GROWTH SERIES)0.00%180,550-45,168-20.01%Dec 31, 2023
DRIEHAUS MUTUAL FUNDS0.00%40,389-16,507-29.01%Dec 29, 2023
FIDELITY CONCORD STREET TRUST0.00%921,90244,5245.07%Feb 29, 2024
Natixis Funds Trust IV0.00%1,282-675-34.49%Jan 31, 2024
NEUBERGER BERMAN EQUITY FUNDS0.00%38,7488,53128.23%Feb 29, 2024
Calvert Variable Products, Inc.0.00%9,3811271.37%Dec 31, 2023
Bernstein Fund Inc0.00%39,580--Dec 31, 2023
Nushares ETF Trust0.00%26,58726,2126989.87%Jan 31, 2024
PFM Multi-Manager Series Trust0.00%2,948--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%4,122-2,018-32.87%Dec 31, 2023
ARCHER INVESTMENT SERIES TRUST0.00%1,040-350-25.18%Feb 29, 2024
ProFunds0.00%29,89911,29160.68%Jan 31, 2024
Goldman Sachs ETF Trust II0.00%3,2703,270-Feb 29, 2024
JANUS INVESTMENT FUND0.00%898,10444,6865.24%Dec 31, 2023
SCHWAB STRATEGIC TRUST0.00%514,95027,3865.62%Feb 29, 2024
SHELTON FUNDS0.00%4,417-234-5.03%Feb 29, 2024
T. Rowe Price Spectrum Funds II, Inc.0.00%37,03410,49139.52%Feb 29, 2024
PROFESSIONALLY MANAGED PORTFOLIOS0.00%13,990--Feb 29, 2024
FIRST TRUST EXCHANGE-TRADED FUND IV0.00%565,000--Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%67,4203,4905.46%Dec 31, 2023
VANGUARD TAX-MANAGED FUNDS0.00%766,052-25,432-3.21%Dec 31, 2023
VICTORY PORTFOLIOS0.00%67,02034,150103.89%Dec 31, 2023
VANGUARD HORIZON FUNDS0.00%46,736--Dec 31, 2023

Cytokinetics's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 285.39K shares, compromising 1.74% of its total assets.

Cytokinetics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24161-61.67%
31 Dec, 2342053.28%
30 Sep, 232745.38%
30 Jun, 23260-1.14%
31 Mar, 23263-8.68%
31 Dec, 222880.70%
30 Sep, 222864.38%
30 Jun, 2227413.22%
31 Mar, 22242-3.97%
31 Dec, 2125216.13%
30 Sep, 2121713.61%
30 Jun, 21191-1.55%
31 Mar, 211942.11%
31 Dec, 20190-6.40%
30 Sep, 2020323.03%
30 Jun, 201658.55%
31 Mar, 201526.29%
31 Dec, 19143-1.38%
30 Sep, 191459.02%
30 Jun, 19133-
31 Mar, 191333.10%
31 Dec, 181299.32%
30 Sep, 18118-3.28%
30 Jun, 18122-1.61%
31 Mar, 18124-5.34%
31 Dec, 17131-5.07%
30 Sep, 17138-
30 Jun, 1713828.97%
31 Mar, 171073.88%
31 Dec, 1610310.75%
30 Sep, 1693-4.12%
30 Jun, 1697-11.01%
31 Mar, 16109-14.17%
31 Dec, 1512719.81%
30 Sep, 151064.95%
30 Jun, 151017.45%
31 Mar, 15949.30%
31 Dec, 14861.18%
30 Sep, 1485-9.57%
30 Jun, 1494-25.40%
31 Mar, 1412641.57%
31 Dec, 1389-9.18%
30 Sep, 1398444.44%
30 Jun, 1318-

As of 31 Mar 24, 161 institutions are holding Cytokinetics's shares, representing a decrease of -61.67% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2435,402,150-68.82%
31 Dec, 23113,525,7374.17%
30 Sep, 23108,984,2570.78%
30 Jun, 23108,144,7700.49%
31 Mar, 23107,621,7891.28%
31 Dec, 22106,258,6651.66%
30 Sep, 22104,527,457-1.32%
30 Jun, 22105,929,08010.97%
31 Mar, 2295,456,1744.62%
31 Dec, 2191,239,6551.23%
30 Sep, 2190,128,63419.35%
30 Jun, 2175,517,5940.99%
31 Mar, 2174,777,5302.61%
31 Dec, 2072,874,7326.21%
30 Sep, 2068,610,92618.66%
30 Jun, 2057,821,6263.84%
31 Mar, 2055,683,2711.45%
31 Dec, 1954,887,57023.88%
30 Sep, 1944,307,3831.55%
30 Jun, 1943,629,84611.44%
31 Mar, 1939,149,941-1.37%
31 Dec, 1839,691,9562.72%
30 Sep, 1838,641,5253.15%
30 Jun, 1837,461,5881.57%
31 Mar, 1836,880,957-3.92%
31 Dec, 1738,385,050-2.90%
30 Sep, 1739,533,2123.39%
30 Jun, 1738,237,39035.09%
31 Mar, 1728,305,1117.30%
31 Dec, 1626,378,809-1.09%
30 Sep, 1626,668,1930.48%
30 Jun, 1626,540,002-0.13%
31 Mar, 1626,573,2790.67%
31 Dec, 1526,395,35322.36%
30 Sep, 1521,571,9884.08%
30 Jun, 1520,725,7155.83%
31 Mar, 1519,584,3851.50%
31 Dec, 1419,294,098-2.22%
30 Sep, 1419,731,356-5.30%
30 Jun, 1420,835,697-7.11%
31 Mar, 1422,429,52422.88%
31 Dec, 1318,252,9591.34%
30 Sep, 1318,011,902567.11%
30 Jun, 132,700,003-

Cytokinetics (CYTK) has 35.40M shares outstanding as of 31 Mar 24, down -68.82% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2435.74%0.26%
31 Dec, 23118.17%0.91%
30 Sep, 23113.82%0.88%
30 Jun, 23113.64%0.89%
31 Mar, 23113.09%0.81%
31 Dec, 22118.30%0.95%
30 Sep, 22111.49%0.73%
30 Jun, 22123.56%0.98%
31 Mar, 22112.31%0.80%
31 Dec, 21118.67%0.94%
30 Sep, 21112.20%1.01%
30 Jun, 21105.25%0.95%
31 Mar, 21105.03%0.82%
31 Dec, 20112.94%1.12%
30 Sep, 20100.49%1.07%
30 Jun, 2097.01%1.10%
31 Mar, 2093.95%1.03%
31 Dec, 1995.33%1.67%
30 Sep, 1975.56%1.32%
30 Jun, 1975.68%1.48%
31 Mar, 1971.41%1.36%
31 Dec, 1872.58%1.45%
30 Sep, 1870.74%1.49%
30 Jun, 1869.00%1.48%
31 Mar, 1868.22%1.35%
31 Dec, 1771.18%1.31%
30 Sep, 1773.59%1.17%
30 Jun, 1779.30%1.71%
31 Mar, 1768.08%1.61%
31 Dec, 1665.00%1.46%
30 Sep, 1666.79%1.49%
30 Jun, 1666.91%1.49%
31 Mar, 1667.12%1.47%
31 Dec, 1567.51%2.18%
30 Sep, 1555.67%1.94%
30 Jun, 1553.52%2.09%
31 Mar, 1550.64%1.84%
31 Dec, 1452.50%1.81%
30 Sep, 1453.90%1.65%
30 Jun, 1457.17%1.24%
31 Mar, 1468.00%1.52%
31 Dec, 1366.92%1.78%
30 Sep, 1361.28%55.83%
30 Jun, 1310.48%-

As of 31 Mar 24, Cytokinetics is held by 35.74% institutional shareholders, representing a 0.26% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2481-59.90%
31 Dec, 2320265.57%
30 Sep, 23122-4.69%
30 Jun, 231289.40%
31 Mar, 23117-20.41%
31 Dec, 22147-3.29%
30 Sep, 221521.33%
30 Jun, 2215025.00%
31 Mar, 22120-9.09%
31 Dec, 21132-7.69%
30 Sep, 2114364.37%
30 Jun, 2187-4.40%
31 Mar, 2191-5.21%
31 Dec, 2096-23.81%
30 Sep, 2012638.46%
30 Jun, 209112.35%
31 Mar, 20813.85%
31 Dec, 19786.85%
30 Sep, 1973-14.12%
30 Jun, 198510.39%
31 Mar, 19778.45%
31 Dec, 187124.56%
30 Sep, 1857-3.39%
30 Jun, 185911.32%
31 Mar, 1853-15.87%
31 Dec, 1763-5.97%
30 Sep, 1767-28.72%
30 Jun, 179451.61%
31 Mar, 176226.53%
31 Dec, 16494.26%
30 Sep, 164742.42%
30 Jun, 1633-23.26%
31 Mar, 1643-42.67%
31 Dec, 157538.89%
30 Sep, 1554-5.26%
30 Jun, 15579.62%
31 Mar, 155220.93%
31 Dec, 14432.38%
30 Sep, 1442-25.00%
30 Jun, 1456-26.32%
31 Mar, 147655.10%
31 Dec, 1349-46.15%
30 Sep, 1391435.29%
30 Jun, 1317-

81 institutional shareholders have increased their position in CYTK stock as of 31 Mar 24 compared to 202 in the previous quarter (a -59.90% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2449-58.12%
31 Dec, 2311746.25%
30 Sep, 23802.56%
30 Jun, 2378-19.59%
31 Mar, 239715.48%
31 Dec, 2284-1.18%
30 Sep, 228511.84%
30 Jun, 2276-8.43%
31 Mar, 22835.06%
31 Dec, 217975.56%
30 Sep, 2145-31.82%
30 Jun, 21664.76%
31 Mar, 21635.00%
31 Dec, 206050.00%
30 Sep, 2040-20.00%
30 Jun, 205021.95%
31 Mar, 20417.89%
31 Dec, 19382.70%
30 Sep, 193776.19%
30 Jun, 1921-16.00%
31 Mar, 1925-28.57%
31 Dec, 18352.94%
30 Sep, 1834-8.11%
30 Jun, 1837-9.76%
31 Mar, 1841-8.89%
31 Dec, 174512.50%
30 Sep, 174048.15%
30 Jun, 1727-
31 Mar, 1727-20.59%
31 Dec, 163470.00%
30 Sep, 1620-48.72%
30 Jun, 1639-2.50%
31 Mar, 16408.11%
31 Dec, 153715.63%
30 Sep, 153218.52%
30 Jun, 1527-3.57%
31 Mar, 15287.69%
31 Dec, 142673.33%
30 Sep, 1415-28.57%
30 Jun, 1421-25.00%
31 Mar, 142812.00%
31 Dec, 1325733.33%
30 Sep, 133-
30 Jun, 13--

49 institutional shareholders have reduced their position in CYTK stock as of 31 Mar 24 compared to 117 in the previous quarter (a -58.12% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24161-61.67%35,402,150-68.82%35.74%0.26%81-59.90%49-58.12%
31 Dec, 2342053.28%113,525,7374.17%118.17%0.91%20265.57%11746.25%
30 Sep, 232745.38%108,984,2570.78%113.82%0.88%122-4.69%802.56%
30 Jun, 23260-1.14%108,144,7700.49%113.64%0.89%1289.40%78-19.59%
31 Mar, 23263-8.68%107,621,7891.28%113.09%0.81%117-20.41%9715.48%
31 Dec, 222880.70%106,258,6651.66%118.30%0.95%147-3.29%84-1.18%
30 Sep, 222864.38%104,527,457-1.32%111.49%0.73%1521.33%8511.84%
30 Jun, 2227413.22%105,929,08010.97%123.56%0.98%15025.00%76-8.43%
31 Mar, 22242-3.97%95,456,1744.62%112.31%0.80%120-9.09%835.06%
31 Dec, 2125216.13%91,239,6551.23%118.67%0.94%132-7.69%7975.56%
30 Sep, 2121713.61%90,128,63419.35%112.20%1.01%14364.37%45-31.82%
30 Jun, 21191-1.55%75,517,5940.99%105.25%0.95%87-4.40%664.76%
31 Mar, 211942.11%74,777,5302.61%105.03%0.82%91-5.21%635.00%
31 Dec, 20190-6.40%72,874,7326.21%112.94%1.12%96-23.81%6050.00%
30 Sep, 2020323.03%68,610,92618.66%100.49%1.07%12638.46%40-20.00%
30 Jun, 201658.55%57,821,6263.84%97.01%1.10%9112.35%5021.95%
31 Mar, 201526.29%55,683,2711.45%93.95%1.03%813.85%417.89%
31 Dec, 19143-1.38%54,887,57023.88%95.33%1.67%786.85%382.70%
30 Sep, 191459.02%44,307,3831.55%75.56%1.32%73-14.12%3776.19%
30 Jun, 19133-43,629,84611.44%75.68%1.48%8510.39%21-16.00%
31 Mar, 191333.10%39,149,941-1.37%71.41%1.36%778.45%25-28.57%
31 Dec, 181299.32%39,691,9562.72%72.58%1.45%7124.56%352.94%
30 Sep, 18118-3.28%38,641,5253.15%70.74%1.49%57-3.39%34-8.11%
30 Jun, 18122-1.61%37,461,5881.57%69.00%1.48%5911.32%37-9.76%
31 Mar, 18124-5.34%36,880,957-3.92%68.22%1.35%53-15.87%41-8.89%
31 Dec, 17131-5.07%38,385,050-2.90%71.18%1.31%63-5.97%4512.50%
30 Sep, 17138-39,533,2123.39%73.59%1.17%67-28.72%4048.15%
30 Jun, 1713828.97%38,237,39035.09%79.30%1.71%9451.61%27-
31 Mar, 171073.88%28,305,1117.30%68.08%1.61%6226.53%27-20.59%
31 Dec, 1610310.75%26,378,809-1.09%65.00%1.46%494.26%3470.00%
30 Sep, 1693-4.12%26,668,1930.48%66.79%1.49%4742.42%20-48.72%
30 Jun, 1697-11.01%26,540,002-0.13%66.91%1.49%33-23.26%39-2.50%
31 Mar, 16109-14.17%26,573,2790.67%67.12%1.47%43-42.67%408.11%
31 Dec, 1512719.81%26,395,35322.36%67.51%2.18%7538.89%3715.63%
30 Sep, 151064.95%21,571,9884.08%55.67%1.94%54-5.26%3218.52%
30 Jun, 151017.45%20,725,7155.83%53.52%2.09%579.62%27-3.57%
31 Mar, 15949.30%19,584,3851.50%50.64%1.84%5220.93%287.69%
31 Dec, 14861.18%19,294,098-2.22%52.50%1.81%432.38%2673.33%
30 Sep, 1485-9.57%19,731,356-5.30%53.90%1.65%42-25.00%15-28.57%
30 Jun, 1494-25.40%20,835,697-7.11%57.17%1.24%56-26.32%21-25.00%
31 Mar, 1412641.57%22,429,52422.88%68.00%1.52%7655.10%2812.00%
31 Dec, 1389-9.18%18,252,9591.34%66.92%1.78%49-46.15%25733.33%
30 Sep, 1398444.44%18,011,902567.11%61.28%55.83%91435.29%3-
30 Jun, 1318-2,700,003-10.48%-17---

Cytokinetics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 07, 2024Malik Fady Ibrahamofficer EVP Research & DevelopmentS-SaleSell14,186$65.11$923.65K138,417
May 07, 2024Malik Fady Ibrahamofficer EVP Research & DevelopmentS-SaleSell1,361$65.11$88.61K137,056

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 07, 2024Malik Fady Ibrahamofficer EVP Research & DevelopmentS-SaleSell14,186$65.11$923.65K138,417
May 07, 2024Malik Fady Ibrahamofficer EVP Research & DevelopmentS-SaleSell1,361$65.11$88.61K137,056
May 07, 2024Malik Fady Ibrahamofficer EVP Research & DevelopmentM-ExemptSell14,186$6.67$94.62K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 16, 2024Bhanji Munadirector-A-AwardBuy5,600--19,631
May 16, 2024Bhanji Munadirector-A-AwardBuy3,636$60.50$219.98K3,636
May 16, 2024COSTA SANTO Jdirector-A-AwardBuy5,600--20,600
May 16, 2024COSTA SANTO Jdirector-A-AwardBuy3,636$60.50$219.98K3,636
May 16, 2024Harrington Robert Arthurdirector-A-AwardBuy5,600--17,121
May 16, 2024Harrington Robert Arthurdirector-A-AwardBuy3,636$60.50$219.98K3,636
May 16, 2024HENDERSON JOHN Tdirector-A-AwardBuy5,600--37,670
May 16, 2024HENDERSON JOHN Tdirector-A-AwardBuy3,636$60.50$219.98K3,636
May 16, 2024Kaye Edward M. MDdirector-A-AwardBuy5,600--24,917
May 16, 2024Kaye Edward M. MDdirector-A-AwardBuy3,636$60.50$219.98K3,636
May 16, 2024PARSHALL B LYNNEdirector-A-AwardBuy5,600--20,600
May 16, 2024PARSHALL B LYNNEdirector-A-AwardBuy3,636$60.50$219.98K3,636
May 16, 2024WIERENGA WENDALLdirector-A-AwardBuy5,600--24,327
May 16, 2024WIERENGA WENDALLdirector-A-AwardBuy3,636$60.50$219.98K3,636
May 16, 2024Wysenski Nancydirector-A-AwardBuy5,600--22,756
May 16, 2024Wysenski Nancydirector-A-AwardBuy3,636$60.50$219.98K3,636
May 07, 2024Malik Fady Ibrahamofficer EVP Research & DevelopmentM-ExemptBuy14,186$6.67$94.62K152,603
May 07, 2024Malik Fady Ibrahamofficer EVP Research & DevelopmentS-SaleSell14,186$65.11$923.65K138,417
May 07, 2024Malik Fady Ibrahamofficer EVP Research & DevelopmentS-SaleSell1,361$65.11$88.61K137,056
May 07, 2024Malik Fady Ibrahamofficer EVP Research & DevelopmentM-ExemptSell14,186$6.67$94.62K-

The last insider sell of Cytokinetics's stock was made by Malik Fady Ibraham on May 07 2024, selling 14,186 shares at $65.11 per share (valued at $923.65K).

Cytokinetics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024188225.00%
Q1 2024272993.10%
Q4 2023141973.68%
Q3 2023162176.19%
Q2 20233117182.35%
Q1 2023293680.56%
Q4 2022141877.78%
Q3 2022244158.54%
Q2 20223222145.45%
Q1 20224337116.22%
Q4 2021344673.91%
Q3 2021232785.19%
Q2 2021464797.87%
Q1 2021434595.56%
Q4 2020245742.11%
Q3 2020173548.57%
Q2 2020324571.11%
Q1 20203116193.75%
Q4 20197977.78%
Q3 2019-6-

18 total buy trades, and 8 total sell trades (buy/sell ratio of 2.25%) were made by Cytokinetics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-5-
Q1 2024-12-
Q4 2023-10-
Q3 2023-11-
Q2 2023-10-
Q1 2023-13-
Q4 2022-10-
Q3 2022-16-
Q2 2022-10-
Q1 2022-8-
Q4 2021-19-
Q3 2021-16-
Q2 2021-24-
Q1 2021-12-
Q4 2020-22-
Q3 2020-18-
Q2 2020-18-
Q1 2020-5-
Q4 201976116.67%
Q3 2019-6-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 5 open market sell trades of Cytokinetics's stocks.

Cytokinetics Peer Ownership


TickerCompany
DICEDICE Therapeutics, Inc.
TERNTerns Pharmaceuticals, Inc.
ABOSAcumen Pharmaceuticals, Inc.
PLRXPliant Therapeutics, Inc.
RLAYRelay Therapeutics, Inc.
ARVNArvinas, Inc.
STOKStoke Therapeutics, Inc.
DYNDyne Therapeutics, Inc.
XFORX4 Pharmaceuticals, Inc.
BDTXBlack Diamond Therapeutics, Inc.
INZYInozyme Pharma, Inc.
EWTXEdgewise Therapeutics, Inc.
RVMDRevolution Medicines, Inc. Warrant
AMLXAmylyx Pharmaceuticals, Inc.
BPMCBlueprint Medicines Corporation
KRTXKaruna Therapeutics, Inc.

CYTK Ownership FAQ


Cytokinetics is owned by institutional shareholders (35.74%), insiders (0.50%), and public (63.76%). The largest institutional shareholder of Cytokinetics is BLACKROCK INC. (12.53% of total shares) and the top mutual fund owner is Manager Directed Portfolios (1.74% of total shares).

Cytokinetics's major institutional shareholders are BLACKROCK INC., FMR LLC, VANGUARD GROUP INC, T. ROWE PRICE INVESTMENT MANAGEMENT, INC., and BANK OF AMERICA CORP /DE/. The top five shareholders own together 43.62% of the company's share outstanding.

As of Mar 2024, there are 161 institutional shareholders of Cytokinetics.

BLACKROCK INC owns 12.41M shares of Cytokinetics, representing 12.53% of the company's total shares outstanding, valued at $870.4M (as of Mar 2024).

As of Mar 2024, FMR LLC holds 10.9M shares of Cytokinetics (CYTK), compromising 11.00% of the company, valued at $764.28M.

VANGUARD GROUP INC is the third largest holder of Cytokinetics. The company owns 10M of the company's shares outstanding (worth $700.89M).